CD8A and neoplasm: Furthermore, by utilizing established murine models, we analyzed matched blood and tumor samples to investigate the mechanisms by which ICB responsiveness is impaired under T-lymphopenic conditions and revealed that, despite a marked reduction in systemic CD8 T cells, a comparable intratumoral CD8 T cell count is maintained.